Ghisallo Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Ghisallo Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-319,358	Closed	-$3.18M	–	266
2022 Q3	$3.18M	Sell	319,358 -300	-0.1%	-$2.98K	0.43%	78
2022 Q2	$3.16M	Hold	319,658	–	–	0.39%	80
2022 Q1	$3.15M	Hold	319,658	–	–	0.34%	98
2021 Q4	$3.12M	Hold	319,658	–	–	0.15%	199
2021 Q3	$3.13M	Sell	319,658 -3,500	-1%	-$34.2K	0.12%	204
2021 Q2	$3.15M	Buy	+323,158	New	+$3.19M	0.12%	215

Ghisallo Capital Management's FLAC Position: Q4 2022 in Review

Ghisallo Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 319,358 shares — an estimated $3.18M sold.

Ghisallo Capital Management first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $3.18M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Ghisallo Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Ghisallo Capital Management sold 319,358 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $3.18M.
Ghisallo Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
Ghisallo Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $3.18M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Ghisallo Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.